A set of biomarkers and clinical variables was found to facilitate the assessment of the risk level for expanded heart failure outcomes in patients with type 2 diabetes mellitus and a recent history of acute coronary syndrome.
Various adipokine and cytokine concentrations may be helpful in predicting the risk for incident diabetes in healthy adults without diabetes.
A distinct association between psoriasis and metabolic and cardiovascular disorders is demonstrated in this study, which also found considerable sex differences in cardiovascular risk factors.
From 2002 to 2015, there was a constant increase in the incidence of type 1 and type 2 diabetes among youth.
Researchers aimed to elucidate the relationship between central obesity and cognition in older adults with T2D.
Linagliptin was not associated with an increased risk of adverse cardiovascular (CV) events, renal events or hypoglycemia in older patients with type 2 diabetes, according to subgroup analysis from the phase 4 Carmelina® trial.
The aims of the study were to discover efficacy of bariatric surgery for remission of diseases related to obesity, estimate metabolic changes over 5 years, and compare the outcomes of restrictive and gastric bypass surgeries.
The association between rosiglitazone and increased cardiovascular risk, especially heart failure, was supported in a set of meta-analyses.
With the use of age-adjusted thresholds for noninvasive markers of liver steatosis and fibrosis, patients with type 2 diabetes may be referred more efficiently to specialists.
Medtronic is recalling certain MiniMed 600 Series insulin pumps due to a missing or broken retainer ring that can potentially lead to the under or over delivery of insulin.